Oligonucleotide Manufacturing Process Development Analytical Methods & Stability Study Oligonucleotide Manufacturing for Clinical Phases Oligonucleotide Manufacturing for Commercial Phases Preparation, aseptic filling or lyophilization Validation & Quality 欢迎选择锐博生物核酸药CDMO/CMO服务 4. CRO/CDMO服务 Welcome to submit CDMO/CMO Service Requests To understand your needs and accelerate your R&D, manufacturing and marketing process, please fill out the form to access timely assessment and consultation. Full Name * Login * Email * Cell Phone * Company * Department/Lab/Research team * Location * China mainland Hong Kong Macau Taiwan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belau Belize Benin Bermuda Bhutan Bolivia Bonaire, Saint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo (Brazzaville) Congo (Kinshasa) Cook Islands Costa Rica Croatia Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hungary Iceland India Indonesia Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Liechtenstein Lithuania Luxembourg North Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint-Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Martin (Dutch part) Saint Pierre and Miquelon Saint Vincent and the Grenadines San Marino Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia/Sandwich Islands South Korea South Sudan Spain Sri Lanka Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom (UK) United States (US) United States (US) Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Virgin Islands (British) Virgin Islands (US) Wallis and Futuna Western Sahara Samoa Yemen Zambia Zimbabwe State/Province * 北京 上海 天津 重庆 广东 江苏 浙江 河北 山东 湖北 湖南 安徽 福建 江西 辽宁 吉林 黑龙江 云南 陕西 内蒙古 河南 广西 海南 四川 贵州 陕西 甘肃 青海 宁夏 西藏 新疆 City * Address * Your project status Drug discovery Preclinical studies Clinical Phase I Clinical phase II Clinical III Pilot Scale-up Commercial production Please select the service you are interested in Drug Target Screening & Validation 寡核苷酸/mRNA药物设计 寡核苷酸/mRNA合成 Lead Molecules Discovery Lead molecules Optimization & Candidates Pharmacological Research Early Toxicity Evaluation Construction of Animal Disease Models Preclinical Pharmacokinetic PKPD Study Development of Drug Delivery System New Drug Application OthersOthers Requirement Detail Do you need Oligo CRO/CDMO manufacturing service? Yes, online form 否 是否需要mRNA生产服务 是,在线填表 否 Oligonucleotide Manufacturing Information Request GMP or non-GMP GMP non-GMP Oligonucleotide Type ssRNA ssDNA dsRNA dsDNA OtherOther length <20 mer 20-30 mer longer mer longer <span style="text-decoration: underline;"> </span> mer </span> Chemical Modifications/ Conjugations 2’OMe 2’F U/C 2’F A/G phosphorthioate cholesterol conjugation OtherOther Product Specification PurityPurity Water contentWater content Sodium contentSodium content EndotoxinEndotoxin Elemental impuritiesElemental impurities Residual solventsResidual solvents Bacterial EndotoxinBacterial Endotoxin Microbial limitMicrobial limit OtherOther Product Specification mgmg gg Process Development Use RiboBio’s standard process. Process development is requested. Transfer process to RiboBio. Analytical Services Use RiboBio’s standard methods. Analytical methods development and validation are requested. Transfer analytical methods to RiboBio. Stability Studies Not requested Long-term stability study for monthsLong-term stability study for <span style="text-decoration: underline;"> </span> months Accelerated stability study Any Additional Information Any other requirements Yes No Please type your requirements Expected time for completion If you are human, leave this field blank. Submit